Potential of TLR agonist as an adjuvant in Leishmania vaccine against visceral leishmaniasis in BALB/c mice.

MLA

Goyal, Deepak Kumar, et al. “Potential of TLR Agonist as an Adjuvant in Leishmania Vaccine against Visceral Leishmaniasis in BALB/c Mice.” Microbial Pathogenesis, vol. 158, Sept. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.micpath.2021.105021.

APA

Goyal, D. K., Keshav, P., & Kaur, S. (2021). Potential of TLR agonist as an adjuvant in Leishmania vaccine against visceral leishmaniasis in BALB/c mice. Microbial Pathogenesis, 158, N.PAG. https://doi.org/10.1016/j.micpath.2021.105021

Chicago

Goyal, Deepak Kumar, Poonam Keshav, and Sukhbir Kaur. 2021. “Potential of TLR Agonist as an Adjuvant in Leishmania Vaccine against Visceral Leishmaniasis in BALB/c Mice.” Microbial Pathogenesis 158 (September): N.PAG. doi:10.1016/j.micpath.2021.105021.